NeuroMetrix, Inc. Common Stock
Compare this stock
NURO Stock Report Card
$
45%
Performance
Score:
10/100
NURO returned -70.24% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.
Analyst Price Targets
Score:
63/100
2 analysts offer 12-month price targets for NURO. Together, they have an average target of 0, the most optimistic target put NURO at 0 within 12-months and the most pessimistic has NURO at 0.
Technicals
Score:
36/100
NURO receives a 35 of 100 based on 14 indicators. 4 are bullish, 8 are bearish.
Earnings
Score:
100/100
NURO has missed earnings 0 times in the last 20 quarters.
Profit
Score:
10/100
Out of the last 20 quarters, NURO has had 1 profitable quarters and has increased their profits year over year on 0 of them.
Volatility
Score:
51/100
NURO has had a higher than average amount of volatility over the last 12 months giving it a score of 50 of 100.
NeuroMetrix, Inc. Common Stock Summary
Nasdaq / NURO
Healthcare
Medical - Devices
NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Checkout Similar Companies
NURO scored poorly on our reportcard. Here are some similar companies and how they performed.